vs
Beam Therapeutics Inc.（BEAM）与null（SWIM）财务数据对比。点击上方公司名可切换其他公司
Beam Therapeutics Inc.的季度营收约是null的1.1倍（$114.1M vs $100.0M），Beam Therapeutics Inc.净利率更高（214.1% vs -7.0%，领先221.1%），Beam Therapeutics Inc.同比增速更快（279.5% vs 14.5%），null自由现金流更多（$14.1M vs $-87.0M）
Beam Therapeutics是一家美国生物技术企业，专注于基因治疗与基因组编辑领域的研发，总部位于马萨诸塞州剑桥市。公司依托CRISPR碱基编辑和先导编辑技术，可通过酶促作用修改DNA序列中的单个核苷酸，且不会造成DNA双链断裂，以此开发相关治疗方案。
该企业是一家源自美国的跨国律师事务所，1934年创立于加利福尼亚州洛杉矶，在诉讼业务、公司法务以及监管合规法律领域拥有深厚的行业积累与知名度，是全球颇具影响力的综合性律所之一。
BEAM vs SWIM — 直观对比
营收规模更大
BEAM
是对方的1.1倍
$100.0M
营收增速更快
BEAM
高出265.0%
14.5%
净利率更高
BEAM
高出221.1%
-7.0%
自由现金流更多
SWIM
多$101.1M
$-87.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.1M | $100.0M |
| 净利润 | $244.3M | $-7.0M |
| 毛利率 | — | 28.0% |
| 营业利润率 | -15.3% | -10.7% |
| 净利率 | 214.1% | -7.0% |
| 营收同比 | 279.5% | 14.5% |
| 净利润同比 | 370.4% | 76.0% |
| 每股收益（稀释后） | $2.53 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BEAMSWIM
| Q4 25 | $114.1M | $100.0M | ||
| Q3 25 | — | $161.9M | ||
| Q2 25 | — | $172.6M | ||
| Q1 25 | — | $111.4M | ||
| Q4 24 | — | $87.3M | ||
| Q3 24 | — | $150.5M | ||
| Q2 24 | — | $160.1M | ||
| Q1 24 | — | $110.6M |
净利润BEAMSWIM
| Q4 25 | $244.3M | $-7.0M | ||
| Q3 25 | — | $8.1M | ||
| Q2 25 | — | $16.0M | ||
| Q1 25 | — | $-6.0M | ||
| Q4 24 | — | $-29.2M | ||
| Q3 24 | — | $5.9M | ||
| Q2 24 | — | $13.3M | ||
| Q1 24 | — | $-7.9M |
毛利率BEAMSWIM
| Q4 25 | — | 28.0% | ||
| Q3 25 | — | 35.4% | ||
| Q2 25 | — | 37.1% | ||
| Q1 25 | — | 29.5% | ||
| Q4 24 | — | 24.6% | ||
| Q3 24 | — | 32.4% | ||
| Q2 24 | — | 33.1% | ||
| Q1 24 | — | 27.7% |
营业利润率BEAMSWIM
| Q4 25 | -15.3% | -10.7% | ||
| Q3 25 | — | 13.3% | ||
| Q2 25 | — | 14.3% | ||
| Q1 25 | — | -4.4% | ||
| Q4 24 | — | -14.9% | ||
| Q3 24 | — | 8.9% | ||
| Q2 24 | — | 12.5% | ||
| Q1 24 | — | -1.9% |
净利率BEAMSWIM
| Q4 25 | 214.1% | -7.0% | ||
| Q3 25 | — | 5.0% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | — | -5.4% | ||
| Q4 24 | — | -33.4% | ||
| Q3 24 | — | 3.9% | ||
| Q2 24 | — | 8.3% | ||
| Q1 24 | — | -7.1% |
每股收益（稀释后）BEAMSWIM
| Q4 25 | $2.53 | $-0.06 | ||
| Q3 25 | — | $0.07 | ||
| Q2 25 | — | $0.13 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | — | $-0.24 | ||
| Q3 24 | — | $0.05 | ||
| Q2 24 | — | $0.11 | ||
| Q1 24 | — | $-0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | — |
| 总债务越低越好 | — | $279.8M |
| 股东权益账面价值 | $1.2B | $405.9M |
| 总资产 | $1.5B | $823.2M |
| 负债/权益比越低杠杆越低 | — | 0.69× |
8季度趋势，按日历期对齐
现金及短期投资BEAMSWIM
| Q4 25 | $1.2B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
总债务BEAMSWIM
| Q4 25 | — | $279.8M | ||
| Q3 25 | — | $281.1M | ||
| Q2 25 | — | $281.5M | ||
| Q1 25 | — | $306.9M | ||
| Q4 24 | — | $281.5M | ||
| Q3 24 | — | $282.8M | ||
| Q2 24 | — | $282.4M | ||
| Q1 24 | — | $282.8M |
股东权益BEAMSWIM
| Q4 25 | $1.2B | $405.9M | ||
| Q3 25 | — | $408.4M | ||
| Q2 25 | — | $398.4M | ||
| Q1 25 | — | $381.1M | ||
| Q4 24 | — | $387.2M | ||
| Q3 24 | — | $416.6M | ||
| Q2 24 | — | $408.1M | ||
| Q1 24 | — | $391.8M |
总资产BEAMSWIM
| Q4 25 | $1.5B | $823.2M | ||
| Q3 25 | — | $844.4M | ||
| Q2 25 | — | $822.1M | ||
| Q1 25 | — | $824.6M | ||
| Q4 24 | — | $794.2M | ||
| Q3 24 | — | $853.4M | ||
| Q2 24 | — | $830.0M | ||
| Q1 24 | — | $808.6M |
负债/权益比BEAMSWIM
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 0.81× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.69× | ||
| Q1 24 | — | 0.72× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-83.3M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $-87.0M | $14.1M |
| 自由现金流率自由现金流/营收 | -76.3% | 14.1% |
| 资本支出强度资本支出/营收 | 3.3% | 9.2% |
| 现金转化率经营现金流/净利润 | -0.34× | — |
| 过去12个月自由现金流最近4个季度 | — | $38.0M |
8季度趋势，按日历期对齐
经营现金流BEAMSWIM
| Q4 25 | $-83.3M | $23.3M | ||
| Q3 25 | — | $51.0M | ||
| Q2 25 | — | $36.0M | ||
| Q1 25 | — | $-46.9M | ||
| Q4 24 | — | $6.2M | ||
| Q3 24 | — | $37.2M | ||
| Q2 24 | — | $52.4M | ||
| Q1 24 | — | $-34.5M |
自由现金流BEAMSWIM
| Q4 25 | $-87.0M | $14.1M | ||
| Q3 25 | — | $45.2M | ||
| Q2 25 | — | $29.1M | ||
| Q1 25 | — | $-50.3M | ||
| Q4 24 | — | $-98.0K | ||
| Q3 24 | — | $33.2M | ||
| Q2 24 | — | $47.9M | ||
| Q1 24 | — | $-39.9M |
自由现金流率BEAMSWIM
| Q4 25 | -76.3% | 14.1% | ||
| Q3 25 | — | 27.9% | ||
| Q2 25 | — | 16.8% | ||
| Q1 25 | — | -45.2% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | — | 22.1% | ||
| Q2 24 | — | 29.9% | ||
| Q1 24 | — | -36.0% |
资本支出强度BEAMSWIM
| Q4 25 | 3.3% | 9.2% | ||
| Q3 25 | — | 3.6% | ||
| Q2 25 | — | 4.0% | ||
| Q1 25 | — | 3.1% | ||
| Q4 24 | — | 7.2% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 4.8% |
现金转化率BEAMSWIM
| Q4 25 | -0.34× | — | ||
| Q3 25 | — | 6.29× | ||
| Q2 25 | — | 2.25× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.32× | ||
| Q2 24 | — | 3.95× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BEAM
| Pfizer | $109.1M | 96% |
| Other | $5.0M | 4% |
SWIM
| In Ground Swimming Pools | $50.2M | 50% |
| Covers | $37.0M | 37% |
| Liners | $12.7M | 13% |
